iRadimed Corporation (IRMD) vs PROCEPT BioRobotics Corporation (PRCT)
iRadimed Corporation and PROCEPT BioRobotics Corporation are both Medical Devices companies. iRadimed Corporation and PROCEPT BioRobotics Corporation are of similar size ($1.1B and $1.0B). PROCEPT BioRobotics Corporation has negative trailing earnings, so its P/E is not meaningful; iRadimed Corporation trades at 47.1×. PROCEPT BioRobotics Corporation grew revenue faster over the last twelve months: 22.7% against 11.2%. iRadimed Corporation has the higher net margin (26.7% vs −32.5%) and the higher return on invested capital (40.4% vs −43.6%). Across the 19 metrics below, iRadimed Corporation leads on 14 and PROCEPT BioRobotics Corporation on 5.
Valuation
Profitability
| Metric | IRMD | PRCT | Medical Devices median |
|---|---|---|---|
| Gross margin | 75.86% | 64.22% | 56.01% |
| Operating margin | 31.92% | (33.86%) | (15.03%) |
| Net margin | 26.70% | (32.54%) | (20.40%) |
| Free cash flow margin | 28.43% | (25.17%) | (7.24%) |
| Return on equity | 23.52% | (30.24%) | (15.32%) |
| Return on assets | 20.82% | (22.12%) | (19.72%) |
| Return on invested capital | 40.36% | (43.57%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack